|Day Low/High||13.41 / 13.72|
|52 Wk Low/High||8.31 / 32.74|
The embattled activist talked about his troubled investment in Valeant, his efforts at Chipotle and what he'd like to see the Trump Administration focus its energy on.
U.S. stock futures and global shares are higher as investors looked to recoup losses from a week that saw volatility rise amid turmoil in the Trump White House.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer analyzes the day's trending stocks on our daily Facebook Live show, which airs weekdays at 10 a.m. EST.
Here's a technical look at how to play six stocks trending higher with unusual volume flows.
Valeant's reducing debt and extending near-term maturities. It may not be on its last leg, the way most investors thought.
But analysts say Valeant still must bolster lackluster sales in key products and crank out some true earnings drivers from its product pipeline.
The Nasdaq ends at a record for the third session in a row as volatility holds near a two-decade low.
The Nasdaq closes at a record for the third session in a row as volatility holds at its lowest level in more than two decades.
The Nasdaq remain in the green, on track to close at another record, as Apple holds above its newly-secured $800 billion market cap level.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending stocks including Allergan, Valeant Pharmaceuticals, Apple, Tesla, Whole Foods and Cimarex Energy.
Stocks hold slightly higher on Tuesday morning as the low-volatility trading environment remains stable on Wall Street.
Valeant, NantKwest and Aralez were among the biotech movers in premarket trading on Tuesday.
The aerospace components maker lightened up on its own estimates for full year results and now expects 2017 earnings per share of $12.09-$12.33, versus an analyst average $12.22 estimate.
Stock futures move higher on Tuesday, setting the S&P 500 and Nasdaq up to notch new intraday records when markets open.
These heavily shorted stocks could squeeze the short-sellers if they report bullish earnings this week.
Some of the biggest names in investing gather in New York City Monday for the annual Sohn Conference.
We're rounding out the end of the earnings season and it's retail's turn to step up to the plate and show us what it's got.
Joe Papa's comments come after a two-year period that has seen Valeant lose over 95% of its value over harsh criticisms of its business.
Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.
Jim Cramer says he respects Buffett's judgment. Cramer's also bullish on some airline stocks.
Jim Cramer says a rally on French election results is fine, but don't forget great U.S. corporate earnings and merger activity.